Issue Date: September 19, 2011
Merck Serono Plans Lab In China
Merck Serono is setting up its China R&D lab within the site of Pharmaron’s new campus at the Beijing Economic & Technological Development Area. The new lab will focus on clinical bioanalysis and biomarker characterization in a Chinese population. It will support Merck Serono’s efforts in the area of personalized medicine for cancer and neurodegenerative diseases. Pharmaron is among China’s five largest pharmaceutical contract research organizations.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society